中文 | English
Return
Total: 179 , 1/18
Show Home Prev Next End page: GO
Author:(Xuefeng XU)

1.Research progress of non-insulin hypoglycemic drugs in the treatment of type 1 diabetes mellitus

Zejie XU ; Jiaoni ZHENG ; Jing LUO ; Liangyu WANG ; Wei YAN ; Qiang HE ; Xuefeng SHAN

China Pharmacy 2026;37(2):263-267

2.Mechanism of Wumen Zhiqiao gancao decoction inhibiting pathological angiogenesis in degenerative intervertebral discs by regulating HIF-1α/VEGF/Ang signal axis

Zeling HUANG ; Zaishi ZHU ; Yuwei LI ; Bo XU ; Junming CHEN ; Baofei ZHANG ; Binjie LU ; Xuefeng CAI ; Hua CHEN

China Pharmacy 2025;36(7):807-814

3.USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3.

Yanghao CHEN ; Bozhi YE ; Diyun XU ; Wante LIN ; Zimin FANG ; Xuefeng QU ; Xue HAN ; Wu LUO ; Chen CHEN ; Weijian HUANG ; Hao ZHOU ; Gaojun WU ; Yi WANG ; Guang LIANG

Acta Pharmaceutica Sinica B 2025;15(3):1643-1658

4.Gallstones, cholecystectomy, and cancer risk: an observational and Mendelian randomization study.

Yuanyue ZHU ; Linhui SHEN ; Yanan HUO ; Qin WAN ; Yingfen QIN ; Ruying HU ; Lixin SHI ; Qing SU ; Xuefeng YU ; Li YAN ; Guijun QIN ; Xulei TANG ; Gang CHEN ; Yu XU ; Tiange WANG ; Zhiyun ZHAO ; Zhengnan GAO ; Guixia WANG ; Feixia SHEN ; Xuejiang GU ; Zuojie LUO ; Li CHEN ; Qiang LI ; Zhen YE ; Yinfei ZHANG ; Chao LIU ; Youmin WANG ; Shengli WU ; Tao YANG ; Huacong DENG ; Lulu CHEN ; Tianshu ZENG ; Jiajun ZHAO ; Yiming MU ; Weiqing WANG ; Guang NING ; Jieli LU ; Min XU ; Yufang BI ; Weiguo HU

Frontiers of Medicine 2025;19(1):79-89

5.Analysis of urinary iodine level in Hashimoto thyroiditis patients

Xiaodie Li ; Yongxia Xu ; Fen Wang ; Wenlu Guo ; Wei Jia ; Xuefeng Wang ; Lang Lang ; Defa Zhu

Acta Universitatis Medicinalis Anhui 2024;59(1):144-148

6.Digital medical 3D technology versus traditional 2D technology in the diagnosis and treatment of solid abdominal tumors in children

Changyao WU ; Qianghui LI ; Weimo ZHOU ; Xuefeng LONG ; Lin XU ; Junli QUAN ; Zhenliang NONG ; Shilan LIANG

Chinese Journal of Primary Medicine and Pharmacy 2024;31(3):338-341

7.Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression

Yifei XU ; Xuefeng ZANG ; Wei CHEN

Chinese Critical Care Medicine 2024;36(3):332-336

8.Investigation and analysis of the current status of transjugular intrahepatic portosystemic shunt treatment for portal hypertension in China

Haozhuo GUO ; Meng NIU ; Haibo SHAO ; Xinwei HAN ; Jianbo ZHAO ; Junhui SUN ; Zhuting FANG ; Bin XIONG ; Xiaoli ZHU ; Weixin REN ; Min YUAN ; Shiping YU ; Weifu LYU ; Xueqiang ZHANG ; Chunqing ZHANG ; Lei LI ; Xuefeng LUO ; Yusheng SONG ; Yilong MA ; Tong DANG ; Hua XIANG ; Yun JIN ; Hui XUE ; Guiyun JIN ; Xiao LI ; Jiarui LI ; Shi ZHOU ; Changlu YU ; Song HE ; Lei YU ; Hongmei ZU ; Jun MA ; Yanming LEI ; Ke XU ; Xiaolong QI

Chinese Journal of Radiology 2024;58(4):437-443

9.Correlation between the expression of miRNA-142-3p,mixed lineage kinase 3 and interleukin-1beta in nucleus pulposus and the degree of lumbar intervertebral disc degeneration

Shuliang ZHOU ; Liang XU ; Xuefeng QIAN ; Jincai ZENG ; Lifan ZHU

Chinese Journal of Tissue Engineering Research 2024;28(2):165-171

10.Comparative analysis of homogeneous phase and vertical auto profile separation phase methods for detecting low-density lipo-protein cholesterol levels

Xiufen XU ; Jihua ZOU ; Kaiyun CHEN ; Wei HU ; Lishan WU ; Xuefeng YU ; Weifeng XU ; Yong XU ; Zhanke WANG

Chinese Journal of Clinical Laboratory Science 2024;42(6):411-415

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 179 , 1/18 Show Home Prev Next End page: GO